GE HealthCare Technologies Inc. (GEHC)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Product Revenue	13.89B	13.66B	13.08B
Product Revenue Growth	1.67%	4.48%	-0.40%
Service Revenue	7.09B	6.96B	6.60B
Service Revenue Growth	1.81%	5.56%	2.68%
Revenue (Total)	20.98B	20.63B	19.67B
Revenue (Total) Growth	1.72%	4.84%	0.61%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Imaging Revenue (Post-Q2 2024)	9.40B	9.25B	8.86B
Imaging Revenue (Post-Q2 2024) Growth	1.72%	4.40%	-1.00%
Advanced Visualization Solutions (AVS) Revenue	5.46B	5.35B	5.13B
Advanced Visualization Solutions (AVS) Revenue Growth	1.91%	4.35%	0.73%
Patient Care Solutions (PCS) Revenue	3.04B	3.09B	3.13B
Patient Care Solutions (PCS) Revenue Growth	-1.55%	-1.25%	-0.54%
Pharmaceutical Diagnostics (PDx) Revenue	3.04B	2.90B	2.51B
Pharmaceutical Diagnostics (PDx) Revenue Growth	4.76%	15.63%	8.76%
Other Revenue	46.00M	40.00M	52.00M
Other Revenue Growth	15.00%	-23.08%	-21.21%
Revenue (Total)	20.98B	20.63B	19.67B
Revenue (Total) Growth	1.72%	4.84%	0.61%

Revenue Breakdown 3

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Patient Care Solutions (PCS) Revenue	3.04B	3.09B	3.13B
Patient Care Solutions (PCS) Revenue Growth	-1.55%	-1.25%	-0.54%
Pharmaceutical Diagnostics (PDx) Revenue	3.04B	2.90B	2.51B
Pharmaceutical Diagnostics (PDx) Revenue Growth	4.76%	15.63%	8.76%
Other Revenue	46.00M	40.00M	52.00M
Other Revenue Growth	15.00%	-23.08%	-21.21%
Revenue (Total)	20.98B	20.63B	19.67B
Revenue (Total) Growth	1.72%	4.84%	0.61%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
USCAN Revenue	9.66B	9.53B	8.98B
USCAN Revenue Growth	1.30%	6.12%	5.03%
EMEA Revenue	5.59B	5.43B	5.05B
EMEA Revenue Growth	3.06%	7.40%	-0.14%
China Revenue	2.23B	2.25B	2.36B
China Revenue Growth	-1.16%	-4.62%	-15.26%
Rest of World Revenue	3.51B	3.42B	3.28B
Rest of World Revenue Growth	2.63%	4.21%	3.86%
Revenue (Total)	20.98B	20.63B	19.67B
Revenue (Total) Growth	1.72%	4.84%	0.61%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Imaging EBIT (Post-Q2 2024)	872.00M	891.00M	962.00M
Imaging EBIT (Post-Q2 2024) Growth	-2.13%	-7.38%	17.17%
Advanced Visualization Solutions (AVS) EBIT	1.21B	1.18B	1.12B
Advanced Visualization Solutions (AVS) EBIT Growth	3.23%	5.10%	-0.53%
Patient Care Solutions (PCS) Segment EBIT	171.00M	209.00M	347.00M
Patient Care Solutions (PCS) Segment EBIT Growth	-18.18%	-39.77%	-9.40%
Pharmaceutical Diagnostics (PDx) Segment EBIT	864.00M	872.00M	783.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth	-0.92%	11.37%	26.90%
Other Segment EBIT	10.00M	7.00M	2.00M
Other Segment EBIT Growth	42.86%	250.00%	-81.82%
Operating Income (Other)	-481.00M	-391.00M	-587.00M
Operating Income (Total)	2.65B	2.76B	2.63B
Operating Income (Total) Growth	-4.13%	5.26%	7.80%

EBIT 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Patient Care Solutions (PCS) Segment EBIT	171.00M	209.00M	347.00M
Patient Care Solutions (PCS) Segment EBIT Growth	-18.18%	-39.77%	-9.40%
Pharmaceutical Diagnostics (PDx) Segment EBIT	864.00M	872.00M	783.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth	-0.92%	11.37%	26.90%
Other Segment EBIT	10.00M	7.00M	2.00M
Other Segment EBIT Growth	42.86%	250.00%	-81.82%
Operating Income (Total)	2.65B	2.76B	2.63B
Operating Income (Total) Growth	-4.13%	5.26%	7.80%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Products Remaining Performance Obligations (RPO)	5.14B	5.00B	4.76B
Products Remaining Performance Obligations (RPO) Growth	2.78%	5.17%	-3.55%
Services Remaining Performance Obligations (RPO)	10.69B	10.73B	9.74B
Services Remaining Performance Obligations (RPO) Growth	-0.37%	10.18%	0.12%
Total Remaining Performance Obligations (RPO)	15.83B	15.73B	14.49B
Total Remaining Performance Obligations (RPO) Growth	0.63%	8.54%	-1.12%

Data Source: Fiscal.ai Last updated: Apr 29, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error